PhospholipaseA2: a key regulator of inflammatory signalling and a connector to fibrosis development in atherosclerosis.

[1]  D. Steinberg,et al.  Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[2]  M. Aviram,et al.  Phospholipase A2-modified LDL is taken up at enhanced rate by macrophages. , 1992, Biochemical and biophysical research communications.

[3]  M. Klagsbrun,et al.  Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human monocytes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[4]  T. Sasaki,et al.  Lysophosphatidylcholine plays an essential role in the mitogenic effect of oxidized low density lipoprotein on murine macrophages. , 1994, The Journal of biological chemistry.

[5]  R. Terkeltaub,et al.  Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[6]  J. Fruchart,et al.  Immunological and functional properties of in vitro oxidized low density lipoprotein. , 1995, Journal of lipid research.

[7]  W. Erl,et al.  Enhancement of monocyte adhesion to endothelial cells by oxidatively modified low-density lipoprotein is mediated by activation of CD11b. , 1995, Biochemical and biophysical research communications.

[8]  R. Deckelbaum,et al.  Oleate and Other Long Chain Fatty Acids Stimulate Low Density Lipoprotein Receptor Activity by Enhancing Acyl Coenzyme A:Cholesterol Acyltransferase Activity and Altering Intracellular Regulatory Cholesterol Pools in Cultured Cells (*) , 1995, The Journal of Biological Chemistry.

[9]  W D Wagner,et al.  A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[10]  M. Kasper,et al.  Secretory group II phospholipase A2 in human atherosclerotic plaques. , 1995, Atherosclerosis.

[11]  T. Matsumura,et al.  Lysophosphatidylcholine potentiates the mitogenic activity of modified LDL for human monocyte-derived macrophages. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[12]  B. Johansen,et al.  Binding of Human Phospholipase A2 Type II to Proteoglycans , 1996, The Journal of Biological Chemistry.

[13]  S. Jackson,et al.  The Bioactive Phospholipid, Lysophosphatidylcholine, Induces Cellular Effects via G-Protein-dependent Activation of Adenylyl Cyclase* , 1996, The Journal of Biological Chemistry.

[14]  S. Kihara,et al.  Role of membrane-anchored heparin-binding epidermal growth factor-like growth factor and CD9 on macrophages. , 1997, The Biochemical journal.

[15]  B. Johansen,et al.  Localization of nonpancreatic secretory phospholipase A2 in normal and atherosclerotic arteries. Activity of the isolated enzyme on low-density lipoproteins. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[16]  T. Matsumura,et al.  Two intracellular signaling pathways for activation of protein kinase C are involved in oxidized low-density lipoprotein-induced macrophage growth. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[17]  W. Jaross,et al.  Minimal oxidation and storage of low density lipoproteins result in an increased susceptibility to phospholipid hydrolysis by phospholipase A2. , 1997, Atherosclerosis.

[18]  T. Shimizu,et al.  Lysophosphatidylcholine transduces Ca2+ signaling via the platelet-activating factor receptor in macrophages. , 1997, The American journal of physiology.

[19]  U. Hedin,et al.  Expression of phospholipase A2 isoforms in human normal and atherosclerotic arterial wall. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[20]  E. Hurt-Camejo,et al.  Ultrastructural localization of secretory type II phospholipase A2 in atherosclerotic and nonatherosclerotic regions of human arteries. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[21]  M. Murakami,et al.  The Functions of Five Distinct Mammalian Phospholipase A2s in Regulating Arachidonic Acid Release , 1998, The Journal of Biological Chemistry.

[22]  G. Bondjers,et al.  Phospholipase A2 type II binds to extracellular matrix biglycan: modulation of its activity on LDL by colocalization in glycosaminoglycan matrixes. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[23]  M. Kuzuya,et al.  Induction of macrophage VEGF in response to oxidized LDL and VEGF accumulation in human atherosclerotic lesions. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[24]  O. Wiklund,et al.  Lysophosphatidylcholine induces the production of IL-1beta by human monocytes. , 1998, Atherosclerosis.

[25]  A. Korotaeva,et al.  Effect of lysophosphatidylcholine on transmembrane signal transduction. , 1998, Biochemistry. Biokhimiia.

[26]  Arto Annila,et al.  Sphingomyelinase Induces Aggregation and Fusion, but Phospholipase A2 Only Aggregation, of Low Density Lipoprotein (LDL) Particles , 1998, The Journal of Biological Chemistry.

[27]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[28]  W. Jaross,et al.  Analysis of secretory group II phospholipase A2 expression in human aortic tissue in dependence on the degree of atherosclerosis. , 1999, Atherosclerosis.

[29]  R. Hundal,et al.  Lysophosphatidylcholine stimulates phospholipase D activity in mouse peritoneal macrophages. , 1999, Journal of lipid research.

[30]  J. Qiao,et al.  Role of group II secretory phospholipase A2 in atherosclerosis: 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[31]  M. Ala-Korpela,et al.  Lipolytic modification of LDL by phospholipase A2 induces particle aggregation in the absence and fusion in the presence of heparin. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[32]  R. Virmani,et al.  Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[33]  B. Johansen,et al.  Molecular basis for the association of group IIA phospholipase A(2) and decorin in human atherosclerotic lesions. , 2000, Circulation research.

[34]  G. Pei,et al.  Lysophosphatidylcholine activates p38 and p42/44 mitogen-activated protein kinases in monocytic THP-1 cells, but only p38 activation is involved in its stimulated chemotaxis. , 2000, Circulation research.

[35]  A. Gomez-Muñoz,et al.  Stimulation of phospholipase D activity by oxidized LDL in mouse peritoneal macrophages. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[36]  K. Kugiyama,et al.  Lysophosphatidylcholine induces urokinase-type plasminogen activator and its receptor in human macrophages partly through redox-sensitive pathway. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[37]  G. Chisolm,et al.  Regulation of cell growth by oxidized LDL. , 2000, Free radical biology & medicine.

[38]  D. Stengel,et al.  Mildly oxidized LDL induces expression of group IIa secretory phospholipase A(2) in human monocyte-derived macrophages. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[39]  S. Ousman,et al.  Lysophosphatidylcholine induces rapid recruitment and activation of macrophages in the adult mouse spinal cord , 2000, Glia.

[40]  O. Witte,et al.  Lysophosphatidylcholine as a Ligand for the Immunoregulatory Receptor G2A , 2001, Science.

[41]  S. Rhee,et al.  Saturated Fatty Acids, but Not Unsaturated Fatty Acids, Induce the Expression of Cyclooxygenase-2 Mediated through Toll-like Receptor 4* , 2001, The Journal of Biological Chemistry.

[42]  P. Kovanen,et al.  Lipolysis of LDL by Human Secretory Phospholipase A2 Induces Particle Fusion and Enhances the Retention of LDL to Human Aortic Proteoglycans , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[43]  C. Weber,et al.  Dissociation of apoptosis induction and CD36 upregulation by enzymatically modified low-density lipoprotein in monocytic cells. , 2002, Biochemical and biophysical research communications.

[44]  Katsutoshi Yamada,et al.  Potent Modification of Low Density Lipoprotein by Group X Secretory Phospholipase A2 Is Linked to Macrophage Foam Cell Formation* , 2002, The Journal of Biological Chemistry.

[45]  P. Libby,et al.  Inflammation and Atherosclerosis , 2002, Circulation.

[46]  Y. Ouchi,et al.  A pivotal role of cytosolic phospholipase A2 in bleomycin-induced pulmonary fibrosis , 2002, Nature Medicine.

[47]  J. Balsinde,et al.  Phospholipase A2 regulation of arachidonic acid mobilization , 2002, FEBS letters.

[48]  Michelle L. Varney,et al.  IL-8 Directly Enhanced Endothelial Cell Survival, Proliferation, and Matrix Metalloproteinases Production and Regulated Angiogenesis1 , 2003, The Journal of Immunology.

[49]  E. Creemers,et al.  The dynamic extracellular matrix: intervention strategies during heart failure and atherosclerosis , 2003, The Journal of pathology.

[50]  A. Aljada,et al.  Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. , 2003, Diabetes.

[51]  O. Wiklund,et al.  Fatty acids modulate the effect of darglitazone on macrophage CD36 expression , 2003, European journal of clinical investigation.

[52]  P. Elson,et al.  Unfolding the pathophysiological role of bioactive lysophospholipids. , 2003, Current drug targets. Immune, endocrine and metabolic disorders.

[53]  B. Johansen,et al.  Role of secretory and cytosolic phospholipase A2 enzymes in lysophosphatidylcholine‐stimulated monocyte arachidonic acid release , 2003, FEBS letters.

[54]  S. Katsuda,et al.  Atherosclerosis and extracellular matrix. , 2003, Journal of atherosclerosis and thrombosis.

[55]  C. Leslie,et al.  Role of cytosolic phospholipase A(2) in prostaglandin E(2) production by lung fibroblasts. , 2012, American journal of respiratory cell and molecular biology.

[56]  N. Webb,et al.  Group V sPLA2 Hydrolysis of Low-Density Lipoprotein Results in Spontaneous Particle Aggregation and Promotes Macrophage Foam Cell Formation , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[57]  B. Johansen,et al.  Modification of LDL with human secretory phospholipase A(2) or sphingomyelinase promotes its arachidonic acid-releasing propensity. , 2004, Journal of lipid research.

[58]  B. Johansen,et al.  Enzymatically modified low-density lipoprotein upregulates CD36 in low-differentiated monocytic cells in a peroxisome proliferator-activated receptor-gamma-dependent way. , 2004, Biochemical pharmacology.

[59]  D. Im,et al.  The action mode of lysophosphatidylcholine in human monocytes. , 2004, Journal of pharmacological sciences.

[60]  G. Bondjers,et al.  Fatty acids induce increased granulocyte macrophage-colony stimulating factor secretion through protein kinase C-activation in THP-1 macrophages , 2004, Lipids.

[61]  Takao Shimizu,et al.  G2A Is a Proton-sensing G-protein-coupled Receptor Antagonized by Lysophosphatidylcholine* , 2004, Journal of Biological Chemistry.

[62]  I. van der Made,et al.  Macrophage-specific overexpression of group IIa sPLA2 increases atherosclerosis and enhances collagen deposition Published, JLR Papers in Press, December 1, 2004. DOI 10.1194/jlr.M400253-JLR200 , 2005, Journal of Lipid Research.

[63]  T. Suganami,et al.  A Paracrine Loop Between Adipocytes and Macrophages Aggravates Inflammatory Changes: Role of Free Fatty Acids and Tumor Necrosis Factor α , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[64]  A. Lusis,et al.  Loss of G2A promotes macrophage accumulation in atherosclerotic lesions of low density lipoprotein receptor-deficient mice Published, JLR Papers in Press, April 16, 2005. DOI 10.1194/jlr.M500085-JLR200 , 2005, Journal of Lipid Research.

[65]  T. Izumi,et al.  Identification of 9-Hydroxyoctadecadienoic Acid and Other Oxidized Free Fatty Acids as Ligands of the G Protein-coupled Receptor G2A* , 2005, Journal of Biological Chemistry.

[66]  Li V. Yang,et al.  Gi-independent macrophage chemotaxis to lysophosphatidylcholine via the immunoregulatory GPCR G2A. , 2005, Blood.

[67]  S. Agaugué,et al.  Lysophosphatidylcholine is a natural adjuvant that initiates cellular immune responses. , 2006, Vaccine.

[68]  P. Reaven,et al.  Elevated Concentrations of Nonesterified Fatty Acids Increase Monocyte Expression of CD11b and Adhesion to Endothelial Cells , 2005, Arteriosclerosis, thrombosis, and vascular biology.